Pascal Morel
Impact in
- Biochemistry top 1%
- Blood transfusion and management
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Blood groups and transfusion
Papers in
- Hematology 31
- Blood groups and transfusion 15
- Acute Myeloid Leukemia Research 7
-
- Blood donation and transfusion practices 26
- Co-authors
- Pierre Fenaux (4 shared papers)Pierre Gallian (22 shared papers)JL Laï (1 shared paper)Pierre Tiberghien (19 shared papers)J L Laï (2 shared papers)F Bauters (4 shared papers)Syria Laperche (23 shared papers)Xavier de Lamballerie (6 shared papers)
- Journals
- Vox Sanguinis (14 papers)Transfusion (14 papers)Transfusion Clinique et Biologique (20 papers)Blood (2 papers)Eurosurveillance (2 papers)
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
Pascal Morel
138 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 118
- Biochemistry 368
- Hematology 647
- Hepatology 386
- Management of Technology and Innovation 255
- Critical Care and Intensive Care Medicine 107
Countries citing papers authored by Pascal Morel
This map shows the geographic impact of Pascal Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Morel more than expected).
Fields of papers citing papers by Pascal Morel
This network shows the impact of papers produced by Pascal Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Morel. The network helps show where Pascal Morel may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Morel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. | 1993 | 254 |
| 2 | 2002 | 217 | |
| 3 | 2016 | 177 | |
| 4 | 1993 | 150 | |
| 5 | Cytogenetics of myelodysplastic syndromes. | 1996 | 146 |
| 6 | 2020 | 113 | |
| 7 | 2005 | 87 | |
| 8 | 2020 | 77 | |
| 9 | 1998 | 74 | |
| 10 | 2016 | 58 | |
| 11 | 1999 | 51 | |
| 12 | 2008 | 51 | |
| 13 | 2008 | 45 | |
| 14 | 2005 | 45 | |
| 15 | 2018 | 43 | |
| 16 | 2005 | 36 | |
| 17 | 1989 | 34 | |
| 18 | The therapeutic dilatation of enteric strictures due to Crohn's disease. | 1986 | 32 |
| 19 | 1998 | 30 | |
| 20 | 2012 | 30 |
About Pascal Morel
Pascal Morel is a scholar working on Hematology, Management of Technology and Innovation, Biochemistry, Epidemiology and Hepatology, having authored 150 papers that have together received 2.6k indexed citations. Recurring topics across this work include Blood donation and transfusion practices (26 papers), Blood transfusion and management (23 papers), Blood groups and transfusion (15 papers), Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (8 papers), Acute Myeloid Leukemia Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Biochemistry (368 citations), Hematology (647 citations), Hepatology (386 citations), Management of Technology and Innovation (255 citations) and Critical Care and Intensive Care Medicine (107 citations). Pascal Morel has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Pierre Fenaux, Pierre Gallian, JL Laï, Pierre Tiberghien, J L Laï, F Bauters, Syria Laperche, Xavier de Lamballerie, Alain Duhamel and Eric Wattel. Their work appears in journals such as Vox Sanguinis, Transfusion, Transfusion Clinique et Biologique, Blood and Eurosurveillance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.